© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Posted 18th February 2020

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Title21

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. From reporting to analytics, Title21 provides all the critical data at your fingertips so the right person has the right data at the right time to make the right decisions. This allows Medical Technologists, Technical and Medical Directors to focus on higher-value work, and ultimately the patient, rather than chasing down paperwork and people.

Earlier this year, Title21 was selected as the Most Outstanding Cell Therapy Software Provider for 2019 by AI’s Global Excellence Award. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Since their inception, Tile21’s Cloud and onpremise software manages critical patient, product and process data for cell and gene therapy, immunotherapy and regenerative medicine to ensure quality, compliance and traceability. Programs that implement Title21 solutions find they can scale more effectively to treat more patients and can also translate products more quickly and efficiently from bench to bedside, delivering the latest innovative therapies to patients faster and more safely.

Title21 has served FDA-regulated life science companies for many years with quality management software, so Title21’s experience has been of great service to the cell therapy segment. “Our technology is extremely flexible due to its configurability on the front end. That means that we can maintain a single code base while meeting each cancer center or cell manufacturers’ specific requirements.”

“Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day.”

“At Title21, we partner with the largest and top-rated cancer hospitals – placing the patient first. One of our greatest testimonials we hear often is that our customers want us to continue to solve more of their challenges with our technology. They ask Title21 to help provide solutions through technology to increase the quality, safety and efficiency of their programs.” Current Title21 customers have a strong influence on the technology roadmap to add value to patient therapeutic care and quality. Analytics and business intelligence are also important and play a significant role in the future of developing new cures and protocols more quickly and efficiently. Cell and gene therapy is a dynamic market and the protocols are changing rapidly as they are improved and refined.

Moving forward, the future looks bright for the team at Title21 as they continue to provide exceptional services and award-winning solutions to hospitals and biotech firms. “Our passion is to serve the many patients and their families who face life-threatening diseases by supporting the leading healthcare institutions and biotech companies with powerful tools that help them deliver innovative treatments to their patients. Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day” remarks Fischer.

Bringing the interview to a close, Lynn signs off by revealing the exciting plans which lie in the pipeline for the business, which includes their ambitions to further expand the business in the years to come, especially with the advancements in immunotherapy technology.

Categories: Innovation


You Might Also Like
Read Full PostRead - Eye Icon
First Boundaries, Then Borders: Why Limits Are Your Friend When It Comes to Global Expansion
News
15/04/2026First Boundaries, Then Borders: Why Limits Are Your Friend When It Comes to Global Expansion

Organisational alignment can be an illusion of proximity, rather than an artefact of design. Within a single market, shared context and informal reinforcement create consistency in practice.

Read Full PostRead - Eye Icon
AVIC Acquires Fourth US Aviation Firm
M&A
15/04/2015AVIC Acquires Fourth US Aviation Firm

The Aviation Industry Corporation of China (AVIC) has completed the acquisition of US company Align Aerospace, it was announced on 10 April.

Read Full PostRead - Eye Icon
Riverbed: SD-WAN’s Latest Innovator
Innovation
05/12/2016Riverbed: SD-WAN’s Latest Innovator

Riverbed is a leading technology provider which supports applications, websites, networks, data centers, the cloud, and remote offices to work more efficiently.

Read Full PostRead - Eye Icon
6 Trade Show Tactics That Maximize B2B Leads
Strategy
23/04/20266 Trade Show Tactics That Maximize B2B Leads

Research shows that while attending trade shows leads to many business cards and conversations with potential clients, those client relationships do not necessarily turn into business relationships. In fact, on average, 80% of B2B clients require a minimum of

Read Full PostRead - Eye Icon
6 Strategies to Maximize Customer Engagement Through Corporate Email Campaigns in 2024
News
08/07/20246 Strategies to Maximize Customer Engagement Through Corporate Email Campaigns in 2024

Image Source: Pexels Most trending innovations, like corporate email campaigns, continue to soar high in 2024 as a reliable cornerstone for maximizing customer engagement. With new technologies and strategies sprouting fast, catching up and staying ahead needs

Read Full PostRead - Eye Icon
The Smart City Technology Market is Expected to Be Worth More Than $27.5 Billion Annually by 2023
Finance
13/02/2015The Smart City Technology Market is Expected to Be Worth More Than $27.5 Billion Annually by 2023

A recent report from Navigant Research examines the strategy and execution of 16 leading smart city suppliers.

Read Full PostRead - Eye Icon
Falcon Certified Public Accountants – Soaring Above the Competition
Finance
04/01/2017Falcon Certified Public Accountants – Soaring Above the Competition

Falcon Certified Public Accountants Ltd., registered with the Hong Kong Institute of Certified Public Accountants, specialises in providing audit, tax and corporate advisory services to a wide range of clients. Founder Gilbert Loke talks us through the firm an

Read Full PostRead - Eye Icon
Why the Project Management Sector Needs a Shake-Up
Innovation
29/10/2024Why the Project Management Sector Needs a Shake-Up

Failing projects result in wasted resources, time and increased risk for companies. They negatively impact staff, customers and clients, costing businesses dearly.

Read Full PostRead - Eye Icon
How a Full HSE policy for a Growing Business Positively Impacts Employee Performance
News
21/09/2023How a Full HSE policy for a Growing Business Positively Impacts Employee Performance

If you’re growing a business, you likely have a long “to-do” list. Let’s look at why having a full Health, Safety and Environment (HSE) policy should be right at the top. Why do you need an HSE policy in place as your business grows, and how can it imp



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow